---
$id: https://graph.org.ai/products/commodity/51171942
$type: Product
source: UNSPSC
code: "51171942"
title: "Gefarnate"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Gefarnate

**UNSPSC Code**: 51171942
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C27H44O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1ISE2Y6ULA, chemically known as 5,9,13-trimethyl-4,8,12-tetradecatrienoic acid 3,7-dimethyl-2,6-octadienyl ester but generally known as gefarnate, which bears US NIH Compound Identifier 5282182. European Medicines Agency schedules Gefarnate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07889MIG. The term GEFARNATE is an International Non-Proprietary Name. World Health Organization schedules gefarnate in its Anatomical Therapeutic Chemical (ATC) Classification. GEFARNATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gefarnate under HS 29161970 and SITC 51379. As of Q4 2014, GEFARNATE remains the US FDA Preferred Term for this commodity. Gefarnate bears US NLM identifiers UMLS ID C0017226 and NCI Concept Code C73187. SMILES: O(C(=O)CC/C=C(/CC/C=C(/CC/C=C(/C)C)C)C)C/C=C(/CC/C=C(/C)C)C.

